Affidea completed the acquisition of Uroviva.

Affidea, a pan-European provider of specialist healthcare services, completed the acquisition of Uroviva, a network of medical specialists providing expertise in urology, gynecology, and oncology. Financial terms were not disclosed. "The acquisition of Uroviva is a defining moment in Affidea Group journey to building a comprehensive, high-quality cancer care network in Europe. By bringing together Switzerland’s foremost urology provider with our existing expertise, we are creating an integrated platform that spans the entire patient journey - from early detection to advanced treatment and long term surveillance," Dr Charles Niehaus, Affidea Executive Director.